![]() |
|
|
K Williams, J Chao, K Kashiwagi, T Masuko and K Igarashi
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6084, USA.
Glutamate and glycine are coagonists that act at distinct sites to activate N-methyl-D-aspartate (NMDA) receptors. In the NR1 subunit of the NMDA receptor, mutation of D732 to glutamate (D732E), asparagine (D732N), alanine (D732A), or glycine (D732G) reduced the potency of glycine by > 4000-fold, but these mutations had no effect on sensitivity to glutamate. Mutations at NR1(D732) also changed sensitivity to the glycine-site agonists D-serine and D-alanine, reducing the potencies and, in some cases, the efficacies of these compounds. Thus, D-serine was a full agonist at the glycine site of receptors containing NR1(D732N) and NR1(D732A), a partial agonist at receptors containing NR1(D732G), and a competitive antagonist at receptors containing NR1(D732). Mutations at NR1(D732) had no effect or produced an increase in sensitivity to the glycine-site antagonists 6,7- dichloroquinoxaline-2,3-dione and 5,7-dichlorokynurenic acid. These mutations did not affect the reversal potential, voltage-dependent block by extracellular Mg2+, block by ifenprodil, or stimulation by spermine at NR1/NR2B receptors. NR2 subunits containing mutations at NR2A(D731) and NR2B(D732), which correspond to NR1(D732), did not produce functional receptors when coexpressed with NR1. Residue D732 in NR1 may be close to a glycine binding site on the NMDA receptor and may directly affect the properties of this site or be critical for coupling of glycine binding to channel activation.
This article has been cited by other articles:
![]() |
P. E. Chen, M. T. Geballe, E. Katz, K. Erreger, M. R. Livesey, K. K. O'Toole, P. Le, C. J. Lee, J. P. Snyder, S. F. Traynelis, et al. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol., January 1, 2008; 586(1): 227 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Awobuluyi, J. Yang, Y. Ye, J. E. Chatterton, A. Godzik, S. A. Lipton, and D. Zhang Subunit-Specific Roles of Glycine-Binding Domains in Activation of NR1/NR3 N-Methyl-D-aspartate Receptors Mol. Pharmacol., January 1, 2007; 71(1): 112 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. A. Wyllie, A. R. Johnston, D. Lipscombe, and P. E. Chen Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit J. Physiol., July 15, 2006; 574(2): 477 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Hansen, R. P. Clausen, E. J. Bjerrum, C. Bechmann, J. R. Greenwood, C. Christensen, J. L. Kristensen, J. Egebjerg, and H. Brauner-Osborne Tweaking Agonist Efficacy at N-Methyl-D-aspartate Receptors by Site-Directed Mutagenesis Mol. Pharmacol., December 1, 2005; 68(6): 1510 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Chen, M. T. Geballe, P. J. Stansfeld, A. R. Johnston, H. Yuan, A. L. Jacob, J. P. Snyder, S. F. Traynelis, and D. J. A. Wyllie Structural Features of the Glutamate Binding Site in Recombinant NR1/NR2A N-Methyl-D-aspartate Receptors Determined by Site-Directed Mutagenesis and Molecular Modeling Mol. Pharmacol., May 1, 2005; 67(5): 1470 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Hu, L. Zhang, R. R. Stewart, and F. F. Weight Arginine 222 in the Pre-transmembrane Domain 1 of 5-HT3A Receptors Links Agonist Binding to Channel Gating J. Biol. Chem., November 21, 2003; 278(47): 46583 - 46589. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Foucaud, B. Laube, R. Schemm, A. Kreimeyer, M. Goeldner, and H. Betz Structural Model of the N-Methyl-D-aspartate Receptor Glycine Site Probed by Site-directed Chemical Coupling J. Biol. Chem., June 20, 2003; 278(26): 24011 - 24017. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-T. Liu, M. W. Hollmann, W.-H. Liu, C. W. Hoenemann, and M. E. Durieux Modulation of NMDA Receptor Function by Ketamine and Magnesium: Part I Anesth. Analg., May 1, 2001; 92(5): 1173 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Mothet, A. T. Parent, H. Wolosker, R. O. Brady Jr., D. J. Linden, C. D. Ferris, M. A. Rogawski, and S. H. Snyder D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor PNAS, April 25, 2000; 97(9): 4926 - 4931. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis The Glutamate Receptor Ion Channels Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Danysz and C. G. Parsons Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Honer, D. Benke, B. Laube, J. Kuhse, R. Heckendorn, H. Allgeier, C. Angst, H. Monyer, P. H. Seeburg, H. Betz, et al. Differentiation of Glycine Antagonist Sites of N-Methyl-D-aspartate Receptor Subtypes. PREFERENTIAL INTERACTION OF CGP 61594 WITH NR1/2B RECEPTORS J. Biol. Chem., May 1, 1998; 273(18): 11158 - 11163. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Anson, P. E. Chen, D. J. A. Wyllie, D. Colquhoun, and R. Schoepfer Identification of Amino Acid Residues of the NR2A Subunit That Control Glutamate Potency in Recombinant NR1/NR2A NMDA Receptors J. Neurosci., January 15, 1998; 18(2): 581 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Wood, H. M.A. VanDongen, and A. M.J. VanDongen An Alanine Residue in the M3-M4 Linker Lines the Glycine Binding Pocket of the N-Methyl-D-aspartate Receptor J. Biol. Chem., February 7, 1997; 272(6): 3532 - 3537. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Abele, K. Keinanen, and D. R. Madden Agonist-induced Isomerization in a Glutamate Receptor Ligand-binding Domain. A KINETIC AND MUTAGENETIC ANALYSIS J. Biol. Chem., July 7, 2000; 275(28): 21355 - 21363. [Abstract] [Full Text] [PDF] |
||||